Rayonier Advanced Materials, Inc. (RYAM)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-09
$8.49-0.59%
Close 2026-09-09 · 1-day change
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-09
Broken: Primary pillar broken — Achieve full-year EBITDA above 2025 levels: EBITDA not reported.
Rayonier Advanced Materials aims to deliver positive free cash flow in 2026. Management targets adjusted free cash flow of $25 million to $30 million in 2025-Q4. A new experienced CEO was appointed in 2026 to drive recovery. The company trades cheaply versus peers with a low price-to-sales ratio.
The company is currently loss-making with negative free cash flow yield. Operating income fell sharply from $10.8 million in 2025-Q4 to -$65.3 million in 2026-Q1. Recent leadership changes and earnings misses show ongoing challenges. The sector faces headwinds, and revenue growth is uncertain.
The market expects about 7% revenue growth next year and values the stock cheaply versus peers. Our fair value is near $23.81, reflecting cautious optimism. We see risk in the turnaround execution and cash flow delivery.
Breaks if: full-year EBITDA in 2026 falls below 2025 levels
Drive EBITDA improvement to exceed full-year 2025 EBITDA results.
Stated as a priority in 2 of last 2 quarters. Management expects full-year EBITDA above 2025 levels. Adjusted EBITDA improved significantly from $8 million in 2026-Q1 to $40 million in 2026-Q2, a 43% increase year-over-year, indicating delivering on EBITDA improvement so far.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround story with a medium confidence level. The company is currently loss-making and has experienced weak recent performance, but management is focused on strategic improvements and cash flow generation.
The market appears to have priced in a low expectations gap, indicating that investors are not overly optimistic about RYAM's near-term prospects. The valuation suggests it is cheap compared to peers, but the fundamentals are not yet supporting a strong recovery.
Management has set priorities to improve cash flow and EBITDA, but recent results show volatility and a high probability of missing earnings in the near term. The company has made some progress, but the overall financial performance remains weak.
The thesis hinges on management's ability to complete its strategic review and communicate a clear path forward by Q4 2026. Additionally, external factors such as inflation trends and performance of sector bellwethers could significantly impact RYAM's recovery.
The most important moves since the prior daily snapshot.
Yes, our read has weakened. The latest earnings miss is a key factor. The company did not meet expectations for its earnings. This performance is below its industry peers.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“Adjusted EBITDA from continuing operations increased to $40 million from $8 million in the first quarter and was up 43% from the prior-year quarter.”
“We continue to expect full-year EBITDA above 2025 levels.”
Breaks if: free cash flow remains negative through FY26
Maintain disciplined execution to generate positive free cash flow for the full year 2026.
Stated as a priority in 3 of last 3 quarters. Management consistently expects positive free cash flow in 2026. Cash from operating activities was $32 million in 2026-Q1 but declined to $5 million in 2026-Q2, reflecting some volatility. Despite this, management affirms the full-year trajectory remains on track, indicating delivering with some quarterly variability.
“Full-year trajectory remains aligned with prior expectations, including generating positive free cash flow in 2026.”
“Continue to expect positive free cash flow in 2026 despite low earnings base.”
“Focus on disciplined execution and cash to deliver positive free cash flow in 2026.”
Breaks if: CEO departure or failure to improve company performance within 1 year
Complete leadership transition by appointing new CEO and President to drive strategic and operational execution.
Newly stated in 2026-Q2. The company appointed Daniel M. Krawczyk as CEO and President in June 2026, completing the leadership transition. This priority is recent and aligns with management’s focus on strategic alternatives and operational execution.
“Board appointed Daniel M. Krawczyk as CEO and President effective immediately.”
Over the next 1 to 3 years, RYAM's performance will depend on management execution and broader market conditions. Not investment advice.